New opportunities for accessing promising non-oncological orphan drugs
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | The Lancet Regional Health. Europe |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666776225000675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849339178771283968 |
|---|---|
| author | Carla E.M. Hollak Carelle C. Reparon-Schuijt Kathelijn Verdeyen Lisa J. Deesker Jaap W. Groothoff Josephine M.I. Vos Atse H. Huisman Silvia van der Flier Anke A.M.G. Pisters-van Roy |
| author_facet | Carla E.M. Hollak Carelle C. Reparon-Schuijt Kathelijn Verdeyen Lisa J. Deesker Jaap W. Groothoff Josephine M.I. Vos Atse H. Huisman Silvia van der Flier Anke A.M.G. Pisters-van Roy |
| author_sort | Carla E.M. Hollak |
| collection | DOAJ |
| format | Article |
| id | doaj-art-06b0a44a466e4c9692d92036eed3eaa5 |
| institution | Kabale University |
| issn | 2666-7762 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Regional Health. Europe |
| spelling | doaj-art-06b0a44a466e4c9692d92036eed3eaa52025-08-20T03:44:11ZengElsevierThe Lancet Regional Health. Europe2666-77622025-05-015210127510.1016/j.lanepe.2025.101275New opportunities for accessing promising non-oncological orphan drugsCarla E.M. Hollak0Carelle C. Reparon-Schuijt1Kathelijn Verdeyen2Lisa J. Deesker3Jaap W. Groothoff4Josephine M.I. Vos5Atse H. Huisman6Silvia van der Flier7Anke A.M.G. Pisters-van Roy8Department of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands; Medicines for Society, Platform at Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands; Corresponding author. Department of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.Department of Health Policy, Health Insurers Netherlands, Zeist, the NetherlandsMedicines for Society, Platform at Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the NetherlandsDepartment of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the NetherlandsDepartment of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the NetherlandsDepartment of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the NetherlandsDepartment of Health Policy, Health Insurers Netherlands, Zeist, the NetherlandsDepartment of Health Policy, Health Insurers Netherlands, Zeist, the NetherlandsDepartment of Health Policy, Health Insurers Netherlands, Zeist, the Netherlandshttp://www.sciencedirect.com/science/article/pii/S2666776225000675 |
| spellingShingle | Carla E.M. Hollak Carelle C. Reparon-Schuijt Kathelijn Verdeyen Lisa J. Deesker Jaap W. Groothoff Josephine M.I. Vos Atse H. Huisman Silvia van der Flier Anke A.M.G. Pisters-van Roy New opportunities for accessing promising non-oncological orphan drugs The Lancet Regional Health. Europe |
| title | New opportunities for accessing promising non-oncological orphan drugs |
| title_full | New opportunities for accessing promising non-oncological orphan drugs |
| title_fullStr | New opportunities for accessing promising non-oncological orphan drugs |
| title_full_unstemmed | New opportunities for accessing promising non-oncological orphan drugs |
| title_short | New opportunities for accessing promising non-oncological orphan drugs |
| title_sort | new opportunities for accessing promising non oncological orphan drugs |
| url | http://www.sciencedirect.com/science/article/pii/S2666776225000675 |
| work_keys_str_mv | AT carlaemhollak newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT carellecreparonschuijt newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT kathelijnverdeyen newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT lisajdeesker newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT jaapwgroothoff newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT josephinemivos newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT atsehhuisman newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT silviavanderflier newopportunitiesforaccessingpromisingnononcologicalorphandrugs AT ankeamgpistersvanroy newopportunitiesforaccessingpromisingnononcologicalorphandrugs |